Facial fillers can provide volume under the skin for various cosmetic benefits. From hiding lines and wrinkles to plumping lips and cheeks, Juvederm® hyaluronic acid formulas can create stunning results. One of the latest Juvederm formulas to be FDA-approved is the Juvederm Volux XC™ treatment, which we offer at RIVKIN Aesthetics.
On August 3, 2022, Allergan Aesthetics, the makers of Juvederm, announced that Juvederm Volux XC treatment was FDA-approved for improving jawline definition. This is the first facial filler approved by the FDA for addressing the jawline and sagging jowls. While facial filler injections have been used off-label for rejuvenating the jawline and jowls for years, Juvederm Volux XC has been proven to provide the results needed to earn FDA approval for this treatment.
Improve Jawline Definition and Get Rid of Sagging Jowls
As the skin loses volume and elasticity, the jaw and jowls are one of the first places to show sagging skin and tissue. The firm jawline of youth can begin to sag, creating a heavier, older appearance. Juvederm Volux XC is a denser hyaluronic acid formula that can add the necessary volume to lift and firm the jawline and jowl area. In clinical trials, Juvederm Volux XC treatment had an extremely high patient satisfaction rate for improving the jawline definition and reducing the appearance of sagging jowls.
Juvederm Volux XC injections can be performed in a quick office visit and do not require any downtime. The treatment results are almost immediate, providing a firmer, more defined jawline and lower face appearance. The results can last 12 months or more before the treatment must be repeated to maintain the desired effect.
If you are unhappy with your jawline definition or the appearance of sagging jowls, come see us at RIVKIN Aesthetics. We offer Juvederm Volux XC treatment, the newest non-surgical jawline definition treatment. Contact us at our cosmetic center in Los Angeles or Beverly Hills, CA, to schedule your treatment or consultation.